AzTrials
AzTrials

Comparative Study(REE)NCT07165080

Comparative Evaluation of smART+ REE Module to an FDA-cleared Device, for REE Calculation in ICU Patients

An observational study of Comparative Study and REE, run by ART Medical Ltd. at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective, single-center, comparative evaluation of smART+ REE Module to an FDA-cleared REE Module device, for REE calculation in ICU Patients. Read more about this study

Who is it for?
Ages 22 years and older
Conditions the study is for
Comparative Study, REE, Resting Energy Expenditure
What is being tested?
smART+ REE
Type of treatment
Medical device
How many people
40 participants
Where
1 siteIsrael
Study dates
12 Aug 2025to 30 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Due to the anticipated dropout rate after one or two measurement rounds, we plan to recruit a minimum of 25 patients and up to 40 patients. Each patient will undergo a maximum of 4 measurement rounds. The study will conclude once 90 measurement rounds have been completed, regardless of the number of patients remaining in the study at that point. All patients enrolled in the study will be mechanically ventilated patients who have already been admitted to the ICU, are eligible for use of the smART+ System and COSMED device, are in a relatively stable condition, and are expected to remain ventilated for at least 24 hours. The study will exclude patients requiring chest drainage, because not all the air exhaled by these patients comes through the ventilator tube (due to the drains collecting air leak), compromising the accuracy of VCO2 measurements.

Who may be able to join

  • Males and females 22 years or older
  • Patient has already been admitted to ICU
  • Patient expected to be ventilated at least 24 hours after enrollment
  • Patients should be stable hemodynamically (no increase/decrease in vasopressors) and respiratory (no change in mechanical ventilation settings) for at least 1 hour prior to initiation of study procedures.

Who cannot join

  • Women who are pregnant
  • Patient requiring chest drainage

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Beilinson Medical Center

    Petah Tikva, Hasharon

Other trials in Israel

About this study

A prospective, single-center, comparative evaluation of smART+ REE Module to an FDA-cleared REE Module device, for REE calculation in ICU Patients.

Read the detailed description

Mechanically ventilated patients are unable to take food orally and therefore are dependent on enteral nutrition for provision of both energy and protein requirements. The conditions of ICU patients dramatically change throughout their ICU stay; "diseases, like particularly sepsis, trauma and burns, cause a clinically relevant increase in resting energy expenditure (REE) of between 40%-80%," and most patients do not reach their required protein and caloric targets. The American Association for Parenteral and Enteral Nutrition (ASPEN) recommends that for patients who are at high risk for malnutrition, efforts should be made to provide >80% of the estimated or calculated energy and protein goal within 48-72 hours, starting with half the patient's calorie goal with the rate slowly increasing over time, in order to achieve the clinical benefit of enteral nutrition over the first week of hospitalization .However, studies have shown that more than 74% of ICU patients failed to receive at least 80% of their prescribed nutrition .

Predictive equations (such as Harris-Benedict equation) or a simple weight-based formula (48.1% and 48.7% respectively) have therefore been the most practiced methods of determining energy needs; however, the literature clearly indicates that each equation has a large potential for error. This makes it difficult to accurately predict an individual patient's energy requirements during critical illness. In general, predictive equations estimate accurately only 50% of the time in ICU patients , leading to over or under evaluation of the nutritional needs and inducing over or underfeeding . Numerous meta-analyses have demonstrated the poor value of predictive equations , , variability that is increased because body weight remains a value difficult to accurately assess .

To overcome the inaccuracy in determining the patient's energy consumption and the accompanying problems, the European Society for Parenteral and Enteral Nutrition (ESPEN) guidelines recommend to determine patients' REE based on indirect calorimetry (IC) or VCO2-based equation (VCO2 x 8.19). Unfortunately, this is not performed continuously during the course of enteral feeding to assess the ever-changing nutritional needs of the patient. Estimations showed that only 2% of ICUs were regularly using REE / IC, and therefore they must resort to performing a one-time calculation of the patient's energy consumption to manually calculate the caloric intake, food type and feeding rate.

This study aims to assess the accuracy of the smART+ System's REE module, compared to the FDA-cleared COSMED device, and nutritional calculations conducted with predictive equations regularly used by the clinical staff at the site.

The smART+ System is a modular nutrition management system intended to be used in a clinical setting. At the heart of the system is the console, which stores, compiles and displays data from the different system modules.

The REE Module is the only feature of the smART+ System being evaluated in this study. The REE Module is comprised of a disposable flow rate meter and a reusable CO2 detector that are added between the patient's endotracheal tube and ventilator tubing. The REE module is designed to continuously measure the patient's energy expenditure and deduce the patient's nutritional requirements according to the following equation:

REE (kcal) = [VCO2 (ml / min) * 3.941 / RQ + VCO2 (ml / min) * 1.11] * 1.44, where RQ=VCO2/VO2 A detailed description of the indirect calorimetry method, based on the above REE equation, is provided in the user manual (IFU) of the smART+ device.

The REE Module is intended to calculate the ventilated patient's REE, based on carbon dioxide monitoring, and deduce the patient's nutritional requirements.

This is a prospective, comparative single-center (three satellites) study assessing the accuracy of the smART+ REE and VCO2 measurements when compared to an FDA-cleared device indicated for REE measurement in ventilated patients (COSMED Q-NRG+ Portable Metabolic Monitor, K190800). The design of the study is as follows:

  1. Each patient will undergo metabolic measurements utilizing both the smART+ System's REE Module and the COSMED device. The particular measurements collected by each device will be: REE, VCO2 and VO2 for the COSMED device, and REE, VCO2 for the smART+ System. A "measurement round" will include REE calculations (which also includes the other metabolic measurements) by both devices, which will be used simultaneously for each patient so as to avoid time-related bias which would ensue if their measurements were taken sequentially (regardless of order). To ensure adequate data is collected for a reliable REE calculation, 20 minutes (+/- 2 minutes) of "stable recording" will be taken, meaning no change in the patient's respiratory and hemodynamic status. To ensure the analysis is performed on a stable recording, the post-analysis of the data collected during the 20-minute recording will focus on the most stable 5-minute segment, determined based on the variability timeframe of the VCO₂ as indicated by the COSMED system. After completing the first measurement round, a minimum wait time of 12 hours is required before beginning the next measurement round. Each patient will undergo up to 4 measurement rounds in total. The metabolic condition of a patient is reflected by O2 consumption and CO2 production, which are continuously changing due to substrate oxidation. To accurately perform indirect calorimetry (IC) measurements, the patient's condition must be stable. That said, the metabolic state of a stable patient may differ from the previous measurement when at least 12 hours have passed. This variability was demonstrated in a study that conducted repeated measurements every hour. Other studies have employed similar approaches. According to the literature, multiple measurements are commonly used to compare metabolic data. For example:
  • The Mindray study included 40 measurements from 16 patients.
  • The Sabatino study analyzed 130 measurements from 42 patients.
  1. For each patient, the parameters used as inputs for calculating REE via the 7 predictive equations listed below will be recorded in the patients' CRFs.
  2. All clinical decisions will be made in accordance with the hospital's Standard of Care (SOC), without any influence from the measurements and calculations obtained during the study (i.e., from the test methods: smART+ System, COSMED device or predictive equations). If one of the tested methods is also used as the SOC in the participating department, the clinical team should continue to follow the department's established SOC without deviation.
  3. Systems connection order on ventilation line: The smART+ REE Module shall be connected first, followed immediately by connection of the COSMED device. This ensures no airflow disruption or interference of one device on the other. Measurements from both devices will be taken simultaneously.
Being tested
smART+ REE
Keywords
Comparative, ICU, REE, COSMED, VCO2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • smART+ REEDevice

    The two study devices will be used simultaneously: the patient's respiratory equipment will be connected directly to the smART+ REE module, and then the COSMED Q-NRG+ will be connected just downstream of that. See the diagram and key below:

Study groups in NCT07165080
Study groupRoleWhat they receive
All participantsThe two study devices will be used simultaneously: the patient's respiratory equipment will be connected directly to the smART+ REE module, and then the COSMED Q-NRG+ will be connected just downstream of that.
Receives: Device: smART+ REE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Compare the resting energy expenditure (REE) calculations obtained with the smART+ REE Module and those obtained with the Q-NRG+ Portable Metabolic Monitor by COSMED (K190800)

    Compare the resting energy expenditure (REE) calculations obtained with the smART+ REE Module and those obtained with the Q-NRG+ Portable Metabolic Monitor by COSMED (K190800), using the root mean squared error (RMSE). The assessment of differences is intended to validate the smART+ REE Module's accuracy when compared to an FDA-cleared device that is representative of "gold standard" measurement for the same purpose.

    Measured: From enrollment until the discharge from the ICU, approximately within 4 days.

Secondary outcomes (2)
  1. Compare the REE measurements obtained with the smART+ and those obtained with the Q-NRG+ Portable Metabolic Monitor, using the relative error (RE).

    Compare the REE measurements obtained with the smART+ and those obtained with the Q-NRG+ Portable Metabolic Monitor, using the relative error (RE).

    Measured: From enrollment until the discharge from the ICU, approximately within 4 days.

  2. Compare the VCO2 measurements obtained with the smART+ and those obtained with the Q-NRG+ Portable Metabolic Monitor, using the relative error (RE).

    Compare the VCO2 measurements obtained with the smART+ and those obtained with the Q-NRG+ Portable Metabolic Monitor, using the relative error (RE).

    Measured: From enrollment until the discharge from the ICU, approximately within 4 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2025
  2. Study start12 Aug 2025
  3. Primary completion21 Oct 2025
  4. Study completion30 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07165080
Sponsor's protocol ID
CRO-J-3356
Acronym
(REE)
Status last verified
Nov 2025
First submitted
21 Apr 2025
Last updated
18 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Comparative Study and REE, run by ART Medical Ltd. at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Compare the resting energy expenditure (REE) calculations obtained with the smART+ REE Module and those obtained with the Q-NRG+ Portable Metabolic Monitor by COSMED (K190800) (time frame: From enrollment until the discharge from the ICU, approximately within 4 days.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in